Divis Laboratories Ltd | DIVI - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Alaunos Therapeutics USD -7.84M 633K 2023-12
Aurobindo Pharma INR 14.04B 1.28B 2025-12
Avita Medical AUD -11.64M 12.13M 2025-12
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Divis Laboratories Ltd INR 8.54B 580M 2025-12
Ionis Pharmaceuticals USD -228M 99M 2025-12
IQVIA Holdings USD 6.16B 5.84B 2025-09
Lupin INR 19.49B 583.6M 2025-12
Moderna USD -187M 631M 2025-09
Organon & Co USD 243M 14M 2025-09
Revvity USD 55.68M 115.97M 2025-09
Tectonic Therapeutic USD -18.97M 63K 2025-12
Tilray USD -39.96M 39.19M 2025-09
Viatris USD -7.9M 209.2M 2025-09
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12